CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
JUVÉDERM VOLUMA™ XCdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02437903
NCT02437903N/ACompleted
CompareCT.gov

Open Label, Single-center Study, Evaluating the Efficacy and Safety of JUVÉDERM VOLUMA™ XC for the Facial Temporal Regions

Baumann Cosmetic and Research Institute·interventional·Posted May 8, 2015·Updated Feb 15, 2018

In Brief

A clinical study evaluating JUVÉDERM VOLUMA™ XC for Aging. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This study is to determine the efficacy and safety of JUVÉDERM VOLUMA™ XC when used in the facial temporal regions based on the change in the score of the investigator's Temporal. This study will be an open label, single center study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAging
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 8, 2015
Enrollment StartAug 7, 2015
Primary CompletionApr 5, 2017
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.2 years ago

Interventions

JUVÉDERM VOLUMA™ XCdevice

Subjects will receive up to 4, 1mL syringes of JUVÉDERM VOLUMA™ XC for their initial injection and a maximum of 6, 1mL syringes of JUVÉDERM VOLUMA™ XC for the study. Subjects will undergo one touch-up injection approximately 2 weeks post initial treatment, and will continue to be evaluated at month 1, month 3, month 6, month 9, and month 12.